- Home
- KLRS vs PED Comparison
KLRS vs PED Comparison
Compare KLRS & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- PED
- Stock Information
- Founded
- KLRS 2019
- PED N/A
- Country
- KLRS United States
- PED United States
- Employees
- KLRS N/A
- PED N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- PED Oil & Gas Production
- Sector
- KLRS Health Care
- PED Energy
- Exchange
- KLRS Nasdaq
- PED Nasdaq
- Market Cap
- KLRS 46.0M
- PED 52.7M
- IPO Year
- KLRS N/A
- PED N/A
- Fundamental
- Price
- KLRS $6.62
- PED N/A
- Analyst Decision
- KLRS Strong Buy
- PED Strong Buy
- Analyst Count
- KLRS 2
- PED 1
- Target Price
- KLRS $23.00
- PED $1.50
- AVG Volume (30 Days)
- KLRS 232.2K
- PED 116.5K
- Earning Date
- KLRS 11-15-2025
- PED 11-13-2025
- Dividend Yield
- KLRS N/A
- PED N/A
- EPS Growth
- KLRS N/A
- PED 569.41
- EPS
- KLRS N/A
- PED 0.14
- Revenue
- KLRS N/A
- PED $35,334,000.00
- Revenue This Year
- KLRS N/A
- PED N/A
- Revenue Next Year
- KLRS N/A
- PED $17.41
- P/E Ratio
- KLRS N/A
- PED $4.27
- Revenue Growth
- KLRS N/A
- PED 3.93
- 52 Week Low
- KLRS $2.14
- PED $0.47
- 52 Week High
- KLRS $24.15
- PED $1.02
- Technical
- Relative Strength Index (RSI)
- KLRS 59.56
- PED 50.10
- Support Level
- KLRS $6.50
- PED $0.57
- Resistance Level
- KLRS $8.80
- PED $0.60
- Average True Range (ATR)
- KLRS 0.95
- PED 0.02
- MACD
- KLRS 0.09
- PED 0.00
- Stochastic Oscillator
- KLRS 51.25
- PED 52.00
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.